Citation:Sun M, Abdollah F, Hansen J, Trinh QD, Bianchi M, Tian Z, et al 2012

Citation

Sun M, Abdollah F, Hansen J, Trinh QD, Bianchi M, Tian Z, et al. Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer? J Sex Med 2012 Nov;9(11):2961-9 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22672479.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Sun M, Abdollah F, Hansen J, Trinh QD, Bianchi M, Tian Z, et al 2012	For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?	Katherine Sheridan	completed
Sun M, Abdollah F, Hansen J, Trinh QD, Bianchi M, Tian Z, et al 2012 2	For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?	Dr Albert Chetcuti BTech(Biotech) Hons, PhD	completed

Compare quality appraisals for each clinical question

• [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?|]] (compare critical appraisals)
• [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does active surveillance achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment?|]] (compare critical appraisals)

Cited by

1. Active surveillance